Save up to 30% on Elsevier print and eBooks with free shipping. No promo code needed.
Save up to 30% on print and eBooks.
Biomarkers in Alzheimer's Disease
1st Edition - August 2, 2016
Author: Tapan Khan
Language: English
Hardback ISBN:9780128048320
9 7 8 - 0 - 1 2 - 8 0 4 8 3 2 - 0
eBook ISBN:9780128051474
9 7 8 - 0 - 1 2 - 8 0 5 1 4 7 - 4
Biomarkers in Alzheimer’s Disease provides a comprehensive overview of all modalities of Alzheimer’s disease biomarkers, including neuroimaging, cerebrospinal fluid, genomic,…Read more
Purchase options
LIMITED OFFER
Save 50% on book bundles
Immediately download your ebook while waiting for your print delivery. No promo code is needed.
Biomarkers in Alzheimer’s Disease provides a comprehensive overview of all modalities of Alzheimer’s disease biomarkers, including neuroimaging, cerebrospinal fluid, genomic, and peripheral systems. Each chapter integrates molecular/cellular abnormality due to Alzheimer’s disease and technological advancement of biomarkers techniques.
The book is ideal for clinical neuroscience and molecular/cellular neuroscience researchers, psychiatrists, and allied healthcare practitioners involved in the diagnosis and management of patients with cognitive impairment and Alzheimer’s disease, and for differential diagnosis of Alzheimer’s disease with other non-Alzheimer’s dementia.
Presents a comprehensive overview detailing all modalities of Alzheimer’s disease biomarkers
Written for neuroscience researchers and clinicians studying or treating patients with Alzheimer’s Disease
Integrates, in each chapter, the molecular/cellular abnormality due to Alzheimer’s disease and the technological advancement of biomarkers techniques
Researchers and clinical practitioners in neurology, general neuroscience, molecular neuroscience, and psychiatry
Dedication
Foreword
Preface
Acknowledgments
Chapter 1: Introduction to Alzheimer’s Disease Biomarkers
Summary
1.1. Historical Background
1.2. Important Events in Alzheimer’s Disease (AD) Research
1.3. Some Facts About Alzheimer’s Disease
1.4. Common Features of Alzheimer’s Disease
1.5. Classification of Alzheimer’s Disease
1.6. Risk Factors for Alzheimer’s Disease
1.7. Definition of a Biomarker
1.8. Biomarkers of Alzheimer’s Disease
1.9. Future Focus: Detecting Preclinical Stages of Alzheimer’s Disease
1.10. Economic Impact of Alzheimer’s Disease Biomarkers
1.11. Conclusions
Chapter 2: Clinical Diagnosis of Alzheimer’s Disease
Summary
2.1. Clinical Diagnosis of Alzheimer’s Disease: Historical Perspective
2.2. Neuropsychological Assessment Tests to Diagnose Alzheimer’s Disease
2.3. Neuropathology at Brain Autopsy to Diagnose Alzheimer’s Disease
2.4. Accuracy of Clinical Diagnosis of Alzheimer’s Disease
7.7. Other Peripheral Cell-Based Biomarkers for Alzheimer’s Disease
7.8. Future Approaches to Cell-Based Alzheimer’s Disease Peripheral Biomarker Discovery
7.9. Advantages and Disadvantages of Cell-Based Alzheimer’s Disease Biomarkers
7.10. Conclusions
Index
No. of pages: 276
Language: English
Edition: 1
Published: August 2, 2016
Imprint: Academic Press
Hardback ISBN: 9780128048320
eBook ISBN: 9780128051474
TK
Tapan Khan
Dr. Khan is an Associate Professor at the Blanchette Rockefeller Neurosciences Institute (BRNI). BRNI is operated in alliance with West Virginia University in Morgantown, USA. Dr. Khan has more than a decade of research experience in the Alzheimer’s disease research area. He is an Associate Editor for Journal of Alzheimer’s Disease and is a regular reviewer for many journals including: European Journal of Pharmaceutical Sciences, Bioorganic & Medicinal Chemistry, CNS & Neurological Disorders-Drug Targets, Neuropeptides, Journal of Biomolecular Structure & Dynamics, Stem Cell Research & Therapy.
Affiliations and expertise
Blanchette Rockefeller Neurosciences Institute, Morgantown WV, USA
Read Biomarkers in Alzheimer's Disease on ScienceDirect